 Patients with cT2-3 N0-1 M0 adenocarcinoma of the oesophagus or junction, based on clinical, CT-PET, and EUS staging, will be randomised to the MAGIC chemotherapy regimen versus the CROSS neoadjuvant chemo radiation protocol prior to surgery. Patients will be randomised to either Arm A MAGIC regimen of chemotherapy only and surgery or Arm B CROSS protocol: chemotherapy with radiation therapy and surgery as per multimodal protocol. 